SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Zymeworks Presents New Phase 1 Data for ZW191 at ESMO

Zymeworks presented new Phase 1 data for its folate receptor alpha-targeting antibody-drug conjugate ZW191 at the ESMO Congress 2026.

ZYME

Related stories